Customer Story Spotlight
When your company is responsible for delivering licensed and unlicensed medicines across five continents, it’s critical to have resilient infrastructure.
FarmaMondo is a Swiss pharmaceutical group that provides patients access to licensed as well as unlicensed medicines across five continents via 14 subsidiaries. The company’s extended supply chain is designed to meet unmet needs for specialty medicines around the world—especially in cases where physicians may not be able to source the pharmaceuticals their patients need. For example, a new medicine might not yet have been licensed in their country or there may be a shortage of an essential drug that has no licensed alternative. In such circumstances, the only option is unlicensed medicines (ULMs). These are products that are not commercially available in the patient’s home market but that healthcare professionals are permitted to source and prescribe when there is no alternative.
FarmaMondo can get those drugs to the right places through its extended supply chain and global network of partners.
